Abstract
Introduction The essential components of a vaccine delivery system are well-documented, but robust evidence on how and why the related processes and implementation strategies prove effective at driving coverage is not well-established. To address this gap, we identified critical success factors associated with advancing key policies and programs that may have led to the substantial changes in routine childhood immunization coverage in Zambia between 2000 and 2018.
Methods We conducted mixed-methods research based on an evidence-based conceptual framework of core vaccine system requirements. Additional facilitators and barriers were explored at the national and subnational levels in Zambia. We conducted a thematic analysis grounded in implementation science frameworks to determine the critical success factors for improved vaccine coverage.
Results The following success factors emerged: 1) the Inter-agency Coordinating Committee was strengthened for long-term engagement which, complemented by the Zambia Immunization Technical Advisory Group, is valued by the government and integrated into national-level decision-making; 2) the Ministry of Health improved the coordination of data collection and review for informed decision-making across all levels; 3) Regional multi-actor committees identified development priorities, strategies, and funding, and iteratively adjusted policies to account for facilitators, barriers, and lessons learned; 4) Vaccine messaging was disseminated through multiple channels, including the media and community leaders, increasing trust in the government by community members; 5) The Zambia Ministry of Health and Churches Health Association of Zambia formalized a long-term organizational relationship to leverage the strengths of faith-based organizations; and 6) Neighborhood Health Committees spearheaded community-driven strategies via community action planning and ultimately strengthened the link between communities and health facilities.
Conclusion Broader health systems strengthening and strong partnerships between various levels of the government, communities, and external organizations were critical factors that accelerated vaccine coverage in Zambia. These partnerships were leveraged to strengthen the overall health system and healthcare governance.
Highlights
This paper describes how policies and programs contributed to improved vaccine coverage in Zambia
Communication, coordination, and collaboration between implementing levels were imperative
Adjacent successes in health systems strengthening and governance were leveraged
Policies in Zambia include flexibility in implementation for tailored approaches in each district
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
Funding provided by the Bill and Melinda Gates Foundation.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
The study was approved by the University of Zambia Biomedical Research Ethics Committee (Federal Assurance No. FWA00000338, REF. No. 166-2019), the National Health Research Authority in Zambia, and the Institutional Review Board committee of Emory University, Atlanta, Georgia, USA (IRB00111474). All participants provided informed consent, either written or with their thumbprint in the presence of a witness after the possible consequences of this study was fully explained.
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Footnotes
Author emails: rodriguez.katie.c{at}gmail.com; kyra.alexandra.hester{at}emory.edu; chamachanda75{at}gmail.com; roopa.darwar{at}alumni.emory.edu; dounebaine{at}gmail.com; anna.s.ellis{at}emory.edu; pinar{at}isye.gatech.edu; bimboleslie{at}yahoo.com; mwangy1980{at}gmail.com; smanyando{at}gmail.com; dima.nazzal{at}gatech.edu; emily.ogutu{at}emory.edu; zoe.marie.sakas{at}emory.edu; fj.castillo.zunino{at}gatech.edu; wkilembe{at}rzhrg-mail.org; robert.a.bednarczyk{at}emory.edu; matthew.freeman{at}emory.edu
Consortium author emails: lbanda{at}rzhrg-mail.org; natalia.bueno{at}emory.edu; matthew.dudgeon{at}emoryhealthcare.org; cescoff{at}emory.edu; kri{at}udel.edu; chandnijaishwal1{at}gmail.com; hanleighj{at}gmail.com; sjuma{at}rzhrg-mail.org; ckabengele{at}rzhrg-mail.org; chandakwendakwape{at}yahoo.com; becky.mackay{at}emory.edu; pablo.montagnes{at}emory.edu; amwaanga{at}rzhrg-mail.org; saad.omer{at}yale.edu; worenst{at}emory.edu; hphiri{at}rzhrg-mail.org; lpilingana{at}gmail.com; miguel.rueda{at}emory.edu; sjohnson333{at}gatech.edu; vivian.tsao{at}emory.edu; zhuoting{at}gatech.edu
Data Availability
available upon request
Abbreviations
- CBV
- Community-based volunteer
- CFHRZ
- Center for Family Health Research in Zambia
- CFIR
- Consolidated Framework for Implementation Research
- CHAZ
- Churches Health Association of Zambia
- CICI
- Context and implementation of complex interventions
- ICC
- Inter-agency Coordinating Committee NHC Neighborhood Health Committee
- ZITAG
- Zambia Immunization Technical Advisory Group
